Livopill-DS Tablet is a combination pharmaceutical formulation containing Metadoxine (500 mg), Silymarin (140 mg), and L-Ornithine L-Aspartate (150 mg), designed to support liver function and promote hepatic detoxification. Metadoxine acts as a hepatoprotective agent by accelerating the metabolism and elimination of toxic substances, particularly in cases of acute and chronic liver disorders. Silymarin, a flavonoid complex derived from milk thistle, exhibits potent antioxidant and anti-inflammatory properties, stabilizing hepatocyte membranes and facilitating liver regeneration. L-Ornithine L-Aspartate contributes to ammonia detoxification by enhancing the urea cycle, thereby reducing hyperammonemia commonly observed in hepatic encephalopathy and other liver dysfunctions. The synergistic action of these active ingredients makes Livopill-DS effective in managing conditions such as alcoholic liver disease, non-alcoholic fatty liver disease, drug-induced hepatotoxicity, and viral hepatitis. This formulation aids in improving liver enzyme profiles, reducing oxidative stress, and restoring normal hepatic metabolism. Livopill-DS is indicated as an adjunctive therapy for patients requiring enhanced liver support and detoxification. It should be used under medical supervision, with dosage adjustments based on clinical response and hepatic function tests. Contraindications include hypersensitivity to any component and severe hepatic impairment without specialist consultation.